We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current DSGN market cap is 339.72M. The company's latest EPS is USD -1.1809 and P/E is -4.92.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -21.65M | -22.6M | -18.82M | -15.12M | -14.4M |
| Net Income | -19.29M | -19.94M | -15.79M | -11.84M | -11.11M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 834k | 226k | 0 | 0 | 0 |
| Operating Income | -1.91M | -8.33M | -35.83M | -67.59M | -78.19M |
| Net Income | -2.05M | -8.28M | -35.53M | -63.31M | -66.86M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 324.74M | 311.63M | 299.87M | 289.64M | 278.79M |
| Total Liabilities | 11.93M | 14.84M | 14.91M | 11.96M | 9.24M |
| Total Equity | 312.82M | 296.8M | 284.96M | 277.69M | 269.56M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 90k | 36.52M | 390.56M | 341.14M | 289.64M |
| Total Liabilities | 3.73M | 2.48M | 8.43M | 13.83M | 11.96M |
| Total Equity | -3.64M | -11.32M | 382.13M | 327.31M | 277.69M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -17.42M | -31.23M | -45.76M | -58.56M | -12.44M |
| Investing | 19.73M | 31.72M | 46.98M | 52.54M | 20.62M |
| Financing | N/A | 210k | 223k | 724k | 20k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -139k | -8.67M | -29.38M | -51.32M | -58.56M |
| Investing | N/A | -33.56M | -53.64M | -220.99M | 52.54M |
| Financing | 196k | 44.53M | 379.21M | 235k | 724k |
| Market Cap | 339.72M |
| Price to Earnings Ratio | -4.92 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 15.52 |
| Price to Book Ratio | 1.18 |
| Dividend Yield | - |
| Shares Outstanding | 56.62M |
| Average Volume (1 week) | 265.55k |
| Average Volume (1 Month) | 135.34k |
| 52 Week Change | 164.32% |
| 52 Week High | 7.77 |
| 52 Week Low | 2.13 |
| Spread (Intraday) | 0.28 (4.64%) |
| Company Name | Design Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.designtx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
